Cristina Rey Blanes is currently a Principal Scientist at Nanopharm Ltd, an Aptar Pharma Company (UK) in the New Modalities Pharmaceutical Development Department.
She studied Biochemistry as Bachelor’s degree at University of Malaga (ES) graduating in 2019, with a thesis on the effect of plant extracts on angiogenesis.
In 2018, she collaborated as a Research Assistant at CIMES in University of Malaga (ES), where she worked on a project characterising immediate early genes in the formation of memory.
In 2020, she obtained a MSc in Advanced Biotechnology in University of Malaga (ES), working on a project focused on bioremediation of pollutants in the environment.
She joined Nanopharm on January of that same year, covering different roles from Pharmaceutical Analyst to her current position as a Principal Scientist. During these two years, she acquired competences in respiratory and nasal drug delivery, focusing particularly on pressurised metered dose inhalers and dry powder inhalers in vitro characterization and generics development. More recently, she started working on the development of nasal sprays comprising antibodies and proteins against viral infections and for nose to brain delivery.
Up to date, she presented her work at a couple of international conferences in nasal and inhalation delivery.